Skip to main content
NCBI home page
Gut logoLink to Gut
. 1984 Sep;25(9):988–998. doi: 10.1136/gut.25.9.988

Antibiotics in the treatment of biliary infection.

J S Dooley, J M Hamilton-Miller, W Brumfitt, S Sherlock
PMCID: PMC1432497  PMID: 6381248

Full text

PDF
988

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acocella G., Mattiussi R., Nicolis F. B., Pallanza R., Tenconi L. T. Biliary excretion of antibiotics in man. Gut. 1968 Oct;9(5):536–545. doi: 10.1136/gut.9.5.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bermúdez R. H., Lugo A., Ramírez-Ronda C. H., Amadeo J. A., Morales J. Amikacin sulfate levels in human serum and bile. Antimicrob Agents Chemother. 1981 Feb;19(2):352–354. doi: 10.1128/aac.19.2.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bevan P. G., Williams J. D. Rifamide in acute cholecystitis and biliary surgery. Br Med J. 1971 Jul 31;3(5769):284–287. doi: 10.1136/bmj.3.5769.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bilbao M. K., Dotter C. T., Lee T. G., Katon R. M. Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10,000 cases. Gastroenterology. 1976 Mar;70(3):314–320. [PubMed] [Google Scholar]
  5. Bishop H. M., Keighley M. R., Crapp A. R., Burdon D. W., Slaney G., AlexanderWilliams J. Proceedings: Gram stain on the bile aspirated at operation: a rational approach to antibiotic therapy in biliary disease. Gut. 1975 Oct;16(10):841–841. [PubMed] [Google Scholar]
  6. Bourgault A. M., England D. M., Rosenblatt J. E., Forgacs P., Bieger R. C. Clinical characteristics of anaerobic bactibilia. Arch Intern Med. 1979 Dec;139(12):1346–1349. [PubMed] [Google Scholar]
  7. Brogard J. M., Dorner M., Pinget M., Adloff M., Lavillaureix J. The biliary excretion of cefazolin. J Infect Dis. 1975 Jun;131(6):625–633. doi: 10.1093/infdis/131.6.625. [DOI] [PubMed] [Google Scholar]
  8. Brogard J. M., Kopferschmitt J., Arnaud J. P., Dorner M., La Villaureix J. Biliary elimination of mezlocillin: an experimental and clinical study. Antimicrob Agents Chemother. 1980 Jul;18(1):69–76. doi: 10.1128/aac.18.1.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brogard J. M., Pinget M., Meyer C., Dorner M., Lavillaureix J. Biliary excretion of ampicillin: experimental and clinical study. Chemotherapy. 1977;23(4):213–226. doi: 10.1159/000221989. [DOI] [PubMed] [Google Scholar]
  10. Chaudhary S., Turner R. B. Trimethoprim-sulfamethoxazole for cholangitis following hepatic portoenterostomy for biliary atresia. J Pediatr. 1981 Oct;99(4):656–658. doi: 10.1016/s0022-3476(81)80286-7. [DOI] [PubMed] [Google Scholar]
  11. Chelvan P., Hamilton-Miller J. M., Brumfitt W. Biliary excretion of erythromycin after parenteral administration. Br J Clin Pharmacol. 1979 Sep;8(3):233–235. doi: 10.1111/j.1365-2125.1979.tb01007.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chetlin S. H., Elliott D. W. Biliary bacteremia. Arch Surg. 1971 Apr;102(4):303–307. doi: 10.1001/archsurg.1971.01350040065012. [DOI] [PubMed] [Google Scholar]
  13. Chetlin S. H., Elliott D. W. Preoperative antibiotics in biliary surgery. Arch Surg. 1973 Aug;107(2):319–323. doi: 10.1001/archsurg.1973.01350200179037. [DOI] [PubMed] [Google Scholar]
  14. Collen M. J., Hanan M. R., Maher J. A., Stubrin S. E. Modification of endoscopic retrograde cholangiopancreatography (ERCP) septic complications by the addition of an antibiotic to the contrast media. Randomized controlled investigation. Am J Gastroenterol. 1980 Dec;74(6):493–496. [PubMed] [Google Scholar]
  15. Crenshaw C. A., Glanges E., Webber C. E., McReynolds D. B. A prospective, randomized, double blind study of preventive cefamandole therapy in patients at high risk for undergoing cholecystectomy. Surg Gynecol Obstet. 1981 Oct;153(4):546–552. [PubMed] [Google Scholar]
  16. DINEEN P. THE IMPORTANCE OF THE ROUTE OF INFECTION IN EXPERIMENTAL BILIARY TRACT OBSTRUCTION. Surg Gynecol Obstet. 1964 Nov;119:1001–1008. [PubMed] [Google Scholar]
  17. Dooley J. S., Gooding A., Hamilton-Miller J. M., Brumfitt W., Sherlock S. The biliary excretion and pharmacokinetics of mezlocillin in jaundiced patients with external bile drainage. Liver. 1983 Aug;3(4):201–206. doi: 10.1111/j.1600-0676.1983.tb00868.x. [DOI] [PubMed] [Google Scholar]
  18. Dye M., MacDonald A., Smith G. The bacterial flora of the biliary tract and liver in man. Br J Surg. 1978 Apr;65(4):285–287. doi: 10.1002/bjs.1800650419. [DOI] [PubMed] [Google Scholar]
  19. EDLUND Y. A., MOLLSTEDT B. O., OUCHTERLONY O. Bacteriological investigation of the biliary system and liver in biliary tract disease correlated to clinical data and microstructure of the gallbladder and liver. Acta Chir Scand. 1959 May 15;116(5-6):461–476. [PubMed] [Google Scholar]
  20. England D. M., Rosenblatt J. E. Anaerobes in human biliary tracts. J Clin Microbiol. 1977 Nov;6(5):494–498. doi: 10.1128/jcm.6.5.494-498.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Engström J., Hellström K., Högman L., Lönnqvist B. Microorganisms of the liver, biliary tract and duodenal aspirates in biliary diseases. Scand J Gastroenterol. 1971;6(2):177–182. doi: 10.3109/00365527109180689. [DOI] [PubMed] [Google Scholar]
  22. Fabre J., Milek E., Kalfopoulos P., Mérier G. La cinétique des tétracyclines chez l'homme. I. Absorption digestive et concentrations sériques. Schweiz Med Wochenschr. 1971 May 1;101(17):593–598. [PubMed] [Google Scholar]
  23. Flemma R. J., Flint L. M., Osterhout S., Shingleton W. W. Bacteriologic studies of biliary tract infection. Ann Surg. 1967 Oct;166(4):563–572. doi: 10.1097/00000658-196710000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Giron J. A., Meyers B. R., Hirschman S. Z. Biliary concentrations of piperacillin in patients undergoing cholecystectomy. Antimicrob Agents Chemother. 1981 Feb;19(2):309–311. doi: 10.1128/aac.19.2.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Goodlin R. C., O'Connell L. P., Gunther R. E. Childbirth chills are they an immunological reaction? Lancet. 1967 Jul 8;2(7506):79–80. doi: 10.1016/s0140-6736(67)92065-x. [DOI] [PubMed] [Google Scholar]
  26. Gozzard D. I., Geddes A. M., Farrell I. D., Eykyn S. J., Phillips I., Wise R., Brown R. M. Ceftazidime--a new extended-spectrum cephalosporin. Lancet. 1982 May 22;1(8282):1152–1156. doi: 10.1016/s0140-6736(82)92228-0. [DOI] [PubMed] [Google Scholar]
  27. Halsall A. K., Welsh C. L., Craven J. L., Hopton D. S., Peel R. N. Prophylactic use of metronidazole in preventing wound sepsis after elective cholecystectomy. Br J Surg. 1980 Aug;67(8):551–552. doi: 10.1002/bjs.1800670806. [DOI] [PubMed] [Google Scholar]
  28. Hares M. M., Hegarty A., Tomkyns J., Burdon D. W., Keighley M. R. A study of the biliary excretion of mecillinam in patients with biliary disease. J Antimicrob Chemother. 1982 Mar;9(3):217–222. doi: 10.1093/jac/9.3.217. [DOI] [PubMed] [Google Scholar]
  29. Helm E. B., Paulus I., Shah P. M., Stille W. Antibakterielle Aktivität von Antibiotika in menschlicher Galle. Infection. 1976;4(2):94–101. doi: 10.1007/BF01638724. [DOI] [PubMed] [Google Scholar]
  30. Jackaman F. R., Hilson G. R., Smith L. Bile bacteria in patients with benign bile duct stricture. Br J Surg. 1980 May;67(5):329–332. doi: 10.1002/bjs.1800670509. [DOI] [PubMed] [Google Scholar]
  31. Jendrzejewski J. W., McAnally T., Jones S. R., Katon R. M. Antibiotics and ERCP: in vitro activity of aminoglycosides when added to iodinated contrast agents. Gastroenterology. 1980 Apr;78(4):745–748. [PubMed] [Google Scholar]
  32. KUNIN C. M., GLAZKO A. J., FINLAND M. Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis. J Clin Invest. 1959 Sep;38:1498–1508. doi: 10.1172/JCI103928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Keighley M. R., Baddeley R. M., Burdon D. W., Edwards J. A., Quoraishi A. H. A controlled trial of parenteral prophylactic gentamicin therapy in biliary surgery. Br J Surg. 1975 Apr;62(4):275–279. doi: 10.1002/bjs.1800620406. [DOI] [PubMed] [Google Scholar]
  34. Keighley M. R., Drysdale R. B., Quoraishi A. H., Burdon D. W., Alexander-Willians J. Antibiotics in biliary disease: the relative importance of antibiotic concentrations in the bile and serum. Gut. 1976 Jul;17(7):495–500. doi: 10.1136/gut.17.7.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Keighley M. R., Flinn R., Alexander-Williams J. Multivariate analysis of clinical and operative findings associated with bilary sepsis. Br J Surg. 1976 Jul;63(7):528–531. doi: 10.1002/bjs.1800630709. [DOI] [PubMed] [Google Scholar]
  36. Keighley M. R., Lister D. M., Jacobs S. I., Giles G. R. Hazards of surgical treatment due to microorganisms in the bile. Surgery. 1974 Apr;75(4):578–583. [PubMed] [Google Scholar]
  37. Kosmidis J., Stathakis C., Mantopoulos K., Pouriezi T., Papathanassiou B., Daikos G. K. Clinical pharmacology of cefotaxime including penetration into bile, sputum, bone and cerebrospinal fluid. J Antimicrob Chemother. 1980 Sep;6 (Suppl A):147–151. doi: 10.1093/jac/6.suppl_a.147. [DOI] [PubMed] [Google Scholar]
  38. Kosmidis J., Williams J. D., Andrews J., Goodall J. A., Geddes A. M. Amoxycillin--pharmacology, bacteriology and clinical studies. Br J Clin Pract. 1972 Jul;26(7):341–346. [PubMed] [Google Scholar]
  39. Low D. E., Micflikier A. B., Kennedy J. K., Stiver H. G. Infectious complications of endoscopic retrograde cholangiopancreatography. A prospective assessment. Arch Intern Med. 1980 Aug;140(8):1076–1077. [PubMed] [Google Scholar]
  40. Lygidakis N. J. Potential hazards of intraoperative cholangiography in patients with infected bile. Gut. 1982 Dec;23(12):1015–1018. doi: 10.1136/gut.23.12.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. MARTINI G. A., PHEAR E. A., RUEBNER B., SHERLOCK S. The bacterial content of the small intestine in normal and cirrhotic subjects: relation to methionine toxicity. Clin Sci. 1957 Feb;16(1):35–51. [PubMed] [Google Scholar]
  42. Morran C., McNaught W., McArdle C. S. Prophylactic co-trimoxazole in biliary surgery. Br Med J. 1978 Aug 12;2(6135):462–464. doi: 10.1136/bmj.2.6135.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Nielsen M. L., Justesen T., Asnaes S. Anaerobic bacteriological study of the human liver--with a critical review of the literature. Scand J Gastroenterol. 1974;9(7):671–677. [PubMed] [Google Scholar]
  44. ORLOFF M. J., PESKIN G. W., ELLIS H. L. A bacteriologic study of human portal blood: implications regarding hepatic ischemia in man. Ann Surg. 1958 Nov;148(5):738–746. doi: 10.1097/00000658-195811000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Ott D. J., Gelfand D. W. Complications of gastrointestinal radiologic procedures: II. Complications related to biliary tract studies. Gastrointest Radiol. 1981 Jan 15;6(1):47–56. doi: 10.1007/BF01890221. [DOI] [PubMed] [Google Scholar]
  46. Papachristodoulou A. J., Mackenzie A., Norman J., Karran S. J. Single dose cephazolin prophylaxis in biliary tract surgery. J R Coll Surg Edinb. 1978 May;23(3):178–183. [PubMed] [Google Scholar]
  47. Pieri F., Andre L. J., Abed L. Etude du metabolisme du métronidazole chez l'homme: demonstration de la presence de cet amoebicide dans la bile. Med Trop (Mars) 1969 May-Jun;29(3):375–376. [PubMed] [Google Scholar]
  48. Pitt H. A., Cameron J. L., Postier R. G., Gadacz T. R. Factors affecting mortality in biliary tract surgery. Am J Surg. 1981 Jan;141(1):66–72. doi: 10.1016/0002-9610(81)90014-3. [DOI] [PubMed] [Google Scholar]
  49. Pitt H. A., Roberts R. B., Johnson W. D., Jr Gentamicin levels in the human biliary tract. J Infect Dis. 1973 Mar;127(3):299–302. doi: 10.1093/infdis/127.3.299. [DOI] [PubMed] [Google Scholar]
  50. Remington J. S., Schimpff S. C. Occasional notes. Please don't eat the salads. N Engl J Med. 1981 Feb 12;304(7):433–435. doi: 10.1056/NEJM198102123040730. [DOI] [PubMed] [Google Scholar]
  51. Sales J. E., Sutcliffe M., O'Grady F. Excretion of clindamycin in the bile of patients with biliary tract disease. Chemotherapy. 1973;19(1):11–15. doi: 10.1159/000221434. [DOI] [PubMed] [Google Scholar]
  52. Schrinner E., Limbert M., Penasse L., Lutz A. Antibacterial activity of cefotaxime and other newer cephalosporins (in vitro and in vivo). J Antimicrob Chemother. 1980 Sep;6 (Suppl A):25–30. doi: 10.1093/jac/6.suppl_a.25. [DOI] [PubMed] [Google Scholar]
  53. Severn M., Powis S. J. Biliary excretion and tissue levels of cefuroxime. A study in eleven patients undergoing cholecystectomy. J Antimicrob Chemother. 1979 Mar;5(2):183–188. doi: 10.1093/jac/5.2.183. [DOI] [PubMed] [Google Scholar]
  54. Soussy C. J., Deforges L. P., Le Van Thoi J., Feghali W., Daval J. R. Cefotaxime concentration in the bile and wall of the gallbladder. J Antimicrob Chemother. 1980 Sep;6 (Suppl A):125–130. doi: 10.1093/jac/6.suppl_a.125. [DOI] [PubMed] [Google Scholar]
  55. Strachan C. J., Black J., Powis S. J., Waterworth T. A., Wise R., Wilkinson A. R., Burdon D. W., Severn M., Mitra B., Norcott H. Prophylactic use of cephazolin against wound sepsis after cholecystectomy. Br Med J. 1977 May 14;1(6071):1254–1256. doi: 10.1136/bmj.1.6071.1254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. TWISS J. R., BERGER W. V., GILLETTE L., ARONSON A. R., SIEGEL L. The biliary excretion of erythromycin (ilotycin). Surg Gynecol Obstet. 1956 Mar;102(3):355–357. [PubMed] [Google Scholar]
  57. Vennes J. A., Jacobson J. R., Silvis S. E. Endoscopic cholangiography for biliary system diagnosis. Ann Intern Med. 1974 Jan;80(1):61–64. doi: 10.7326/0003-4819-80-1-61. [DOI] [PubMed] [Google Scholar]
  58. Wacha H., Helm E. B. Efficacy of antibiotics in bacteriobilia. J Antimicrob Chemother. 1982 Jan;9 (Suppl A):131–137. doi: 10.1093/jac/9.suppl_a.131. [DOI] [PubMed] [Google Scholar]
  59. Welch J. P., Donaldson G. A. The urgency of diagnosis and surgical treatment of acute suppurative cholangitis. Am J Surg. 1976 May;131(5):527–532. doi: 10.1016/0002-9610(76)90003-9. [DOI] [PubMed] [Google Scholar]
  60. Welton J. C., Marr J. S., Friedman S. M. Association between hepatobiliary cancer and typhoid carrier state. Lancet. 1979 Apr 14;1(8120):791–794. doi: 10.1016/s0140-6736(79)91315-1. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES